Submission Details
| 510(k) Number | K241313 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2024 |
| Decision Date | May 30, 2025 |
| Days to Decision | 386 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K241313 is an FDA 510(k) clearance for the OHC COVID-19 Antigen Self Test, a Over-the-counter Covid-19 Antigen Test (Class II — Special Controls, product code QYT), submitted by Osang, LLC (Pasadena, US). The FDA issued a Cleared decision on May 30, 2025, 386 days after receiving the submission on May 9, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3984.
| 510(k) Number | K241313 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2024 |
| Decision Date | May 30, 2025 |
| Days to Decision | 386 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QYT — Over-the-counter Covid-19 Antigen Test |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3984 |
| Definition | For The Rapid, Qualitative Detection Of Sars-cov-2 Virus Nucleocapsid Protein Antigen In Individuals 2 Years And Older. |